Click logos to view articles 2020 Vaccine Opportunities and Risks Operation Warp Speed The two sides of America’s coronavirus response Russian Coronavirus Controversy Russia’s coronavirus vaccine: will it work, and is it safe? How do we learn to live with COVID-19 if we’re still waiting for a vaccine a year from now? Race to distribute vaccine in danger without winning public’s trust, researchers say First Covid-19 vaccines due early 2021, but can they deliver as promised? AstraZeneca Signs First COVID-19 Vaccine Deal with China’s Shenzhen Kangtai Medical Experts Wary of “Warp Speed” Coronavirus Vaccine Why scientists are worried about a ‘Warp Speed’ COVID-19 vaccine Making Sure We Get a Safe & Effective Coronavirus Vaccine A Covid-19 vaccine, amazingly, is close. Why am I so worried? What’s With the Quick Russian Coronavirus Vaccine Approval? Even With A Vaccine, It Will Take Months If Not Years to Beat the Coronavirus A Coronavirus Vaccine Won’t Change the World Right Away The US Government Gets in the Vaccine Business Double-Shot Covid Vaccines Multiply Immunization Challenges COVID-19 vaccine researchers draw on knowledge from history’s ‘huge disasters’ and success stories The Economics Of Vaccine PricingPlanet Money The need for a balanced COVID-19 portfolio COVID Gives Big Pharma a Chance to Revive Its Brutal Image Partying American Just Got a Reality Check From The Coronavirus The First Covid Vaccines May Not Prevent Covid Infection Can Operation Warp Speed deliver a COVID–19 vaccine by the end of the year Addressing rumors, conspiracy theories related to coronavirus The Pandemic’s Most Bitter Pill The Race for a Coronavirus Vaccine Everything Old is New Again The Race for a Cure Slow down with the vaccine optimism. We have a long way to go. Should researchers deliberately infect volunteers with coronavirus to test vaccines? Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image The FDA used expanded power to fight the coronavirus. Will future credibility suffer? Coronavirus Facts Only Covid Exit Strategy Depends on Getting Vaccine to Whole World Five myths about vaccines It is Impossible to Have a Vaccine by End of Year What a sugar cube can teach us as we develop a coronavirus vaccine Coronavirus Vaccine in 18 Months? Experts Urge Reality Check Vaccine Experts Inject Realism Into US Gov’t’s COVID-19 Timeline Covid-19 and the Race to Develop a Vaccine The Body: A Guide for Occupants In a period of ‘social distancing,’ reading history might valuably occupy your time Debunking Myths About COVID-19, Treatment, Vaccines A book that should interest everyone who has a body 2e vague du coronavirus : inquiétude en Allemagne, un scénario similaire en France ? An Optimist’s View of the COVID-19 Outbreak 2019 What You Should Read to Understand the Measles Epidemic The return of cancer’s magic bullet The End of the Beginning: Cancer, Immunity, and the Future of a Cure A cancer researcher chronicles the history of the disease and the prospects in the search for a cure. The C-word. Michael Kinch’s new book and the future of Cancer Treatment Medical History: Vaccines and Immunity Wash U’s Michael Kinch Traces Past, Future Of Cancer In ‘The End Of The Beginning’ 2018 TURNS OUT ANTI-VAXXERS WERE AROUND EVEN BEFORE VACCINES Current State of the Vaccine Wars New Book: Vaccines Have Always Had Haters Wash U administrator’s new book explores history, future of vaccination The Sniping Scientists Whose Work Saved Millions of Lives ‘Between Hope and Fear’ Review: Anxieties Immune to Reason Why vaccinations are lifesavers 2017 Mining data for the history of pharmaceutical development 2016 Arrested development Drug Industry In Peril 2015 Restarting the Antibiotic Pipeline Antibiotics shortages could put patients at risk from superbugs Antibiotic Shortages On the Rise in U.S. University-industry partnerships can help tackle antibiotic resistant bacteria Antibiotic Pulled From Dirt Is a Breakthrough, But Don’t Celebrate Just Yet 2014 A Dearth in Innovation for Key Drugs A History of Drugs, Compiled The Dwindling Stock of Antibiotics, and What to Do About It How Many Drug Companies Manage to Get Two New Drugs Approved by FDA? Not Many What to do about the dwindling stock of antibiotics Merck invests in new antibiotics The end of antibiotics? Researchers warn of critical shortages The Antibiotic Arms Race Has a Capitalism Problem The Importance of Protecting Biotech R&D How To Fill The Antibiotic Void Amoxicillin to Zoloft: History of drug development chronicled ‘The process by which drugs are discovered and developed will be fundamentally different in the future’